EUVIMEDEUVIMED entdecken
Crossref

Sustained Within-season Vaccine Effectiveness Against Influenza-associated Hospitalization in Children: Evidence From the New Vaccine Surveillance Network, 2015–2016 Through 2019–2020

Leila C Sahni, Eric A Naioti, Samantha M Olson, Angela P Campbell, Marian G Michaels, John V Williams, Mary Allen Staat, Elizabeth P Schlaudecker, Monica M McNeal, Natasha B Halasa, Laura S Stewart, James D Chappell und 14 weitere

Clinical Infectious Diseases · 08.02.2023 · 76 (3) · e1031-e1039

DOI: 10.1093/cid/ciac577 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 22.07.2022. Verfasst von Leila C Sahni und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA. Hauptthemen laut MEDLINE: Influenza, Human, Influenza Vaccines. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: NCIRD CDC HHS, CDC HHS, Centers for Disease Control and Prevention.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Adult studies have demonstrated within-season declines in influenza vaccine effectiveness (VE); data in children are limited.

Methods

We conducted a prospective, test-negative study of children 6 months through 17 years hospitalized with acute respiratory illness at 7 pediatric medical centers during the 2015–2016 through 2019–2020 influenza seasons. Case-patients were children with an influenza-positive molecular test matched by illness onset to influenza-negative control-patients. We estimated VE [100% × (1 – odds ratio)] by comparing the odds of receipt of ≥1 dose of influenza vaccine ≥14 days before illness onset among influenza-positive children to influenza-negative children. Changes in VE over time between vaccination date and illness onset date were estimated using multivariable logistic regression.

Results

Of 8430 children, 4653 (55%) received ≥1 dose of influenza vaccine. On average, 48% were vaccinated through October and 85% through December each season. Influenza vaccine receipt was lower in case-patients than control-patients (39% vs 57%, P < .001); overall VE against hospitalization was 53% (95% confidence interval [CI]: 46, 60%). Pooling data across 5 seasons, the odds of influenza-associated hospitalization increased 4.2% (−3.2%, 12.2%) per month since vaccination, with an average VE decrease of 1.9% per month (n = 4000, P = .275). Odds of hospitalization increased 2.9% (95% CI: −5.4%, 11.8%) and 9.6% (95% CI: −7.0%, 29.1%) per month in children ≤8 years (n = 3084) and 9–17 years (n = 916), respectively. These findings were not statistically significant.

Conclusions

We observed minimal, not statistically significant within-season declines in VE. Vaccination following current Advisory Committee on Immunization Practices (ACIP) guidelines for timing of vaccine receipt remains the best strategy for preventing influenza-associated hospitalizations in children.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza, HumanInfluenza VaccinesAdultChildHumansSeasonsProspective StudiesVaccine EfficacyCase-Control StudiesVaccinationHospitalizationInfluenza A Virus, H3N2 Subtype

Stichwörter der Autor:innen

case controlinfluenzapediatricsvaccination

Substanzen

Influenza Vaccines

Autor:innen und Institutionen

  • Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
  • Texas Children's Hospital, Houston, Texas, USA.
  • Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • UPMC Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Department of Pediatrics, Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center Cincinnati, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Vanderbilit University Medical Center, Nashville, Tennessee, USA.

Förderung

  • NCIRD CDC HHS
  • CDC HHS
  • Centers for Disease Control and Prevention

Zitieren

APA

Sahni, L. C., Naioti, E. A., Olson, S. M., Campbell, A. P., Michaels, M. G., Williams, J. V., Staat, M. A., Schlaudecker, E. P., McNeal, M. M., Halasa, N. B., Stewart, L. S., Chappell, J. D., Englund, J. A., Klein, E. J., Szilagyi, P. G., Weinberg, G. A., Harrison, C. J., Selvarangan, R., Schuster, J. E., …, & Boom, J. A. (2023). Sustained Within-season Vaccine Effectiveness Against Influenza-associated Hospitalization in Children: Evidence From the New Vaccine Surveillance Network, 2015–2016 Through 2019–2020. Clinical Infectious Diseases, 76(3), e1031-e1039. https://doi.org/10.1093/cid/ciac577

Vancouver

Sahni LC, Naioti EA, Olson SM, Campbell AP, Michaels MG, Williams JV, et al. Sustained Within-season Vaccine Effectiveness Against Influenza-associated Hospitalization in Children: Evidence From the New Vaccine Surveillance Network, 2015–2016 Through 2019–2020. Clinical Infectious Diseases. 2023;76(3):e1031-e1039. doi:10.1093/cid/ciac577

BibTeX
@article{Sahni2023,
  author = {Sahni, Leila C and Naioti, Eric A and Olson, Samantha M and Campbell, Angela P and Michaels, Marian G and Williams, John V and Staat, Mary Allen and Schlaudecker, Elizabeth P and McNeal, Monica M and Halasa, Natasha B and Stewart, Laura S and Chappell, James D and Englund, Janet A and Klein, Eileen J and Szilagyi, Peter G and Weinberg, Geoffrey A and Harrison, Christopher J and Selvarangan, Rangaraj and Schuster, Jennifer E and Azimi, Parvin H and Singer, Monica N and Avadhanula, Vasanthi and Piedra, Pedro A and Munoz, Flor M and Patel, Manish M and Boom, Julie A},
  title = {Sustained Within-season Vaccine Effectiveness Against Influenza-associated Hospitalization in Children: Evidence From the New Vaccine Surveillance Network, 2015–2016 Through 2019–2020},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  volume = {76},
  number = {3},
  pages = {e1031--e1039},
  doi = {10.1093/cid/ciac577}
}
Kostenlos starten →